Anti-oxidant, anti-inflammatory and anti-angiogenic properties of resveratrol in ocular diseases

Molecules

Volumn 21, Issue 3, 2016, Pages

  Lançon, Allan ^a   Frazzi, Raffaele ^b   Latruffe, Norbert ^a  

^a Faculté des Sciences Gabriel   (France)

^b S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Eyes; Inflammation; Resveratrol

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; DISEASE MODEL; DRUG EFFECTS; EYE DISEASES; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PRECLINICAL STUDY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EYE DISEASES; GENE EXPRESSION REGULATION; HUMANS; STILBENES;

EID: 84963690003     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21030304     Document Type: Review

References (36)

1. Takaoka, M.J. Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). J. Fac. Sci. Hokkaido Imp. Univ. 1940, 3, 1-16. [CrossRef]
2. Nonomura, S.; Kanagawa, H.; Makimoto, A. Chemical Constituents of Polygonaceous Plants. I. Studies on the Components of Ko-J O-Kon. (Polygonum Cuspidatum Sieb. Et Zucc.). Yakugaku Zasshi 1963, 83, 988-990. [PubMed]
3. Langcake, P.; Pryce, R.J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol. 1976, 9, 77-86. [CrossRef]
4. Delmas, D.; Jannin, B.; Latruffe, N. Resveratrol: Preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 2005, 49, 377-395. [CrossRef] [PubMed]
5. Colin, D.; Gimazane, A.; Lizard, G.; Izard, J.C.; Solary, E.; Latruffe, N.; Delmas, D. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5-fluoro-uracil sensitivity in human derived colon cancer cells. Int. J. Cancer 2009, 124, 2780-2788. [CrossRef] [PubMed]
6. Richard, T.; Pawlus, A.D.; Iglésias, M.L.; Pedrot, E.; Waffo-Teguo, P.; Mérillon, J.M.; Monti, J.P. Neuroprotective properties of resveratrol and derivatives. Ann. N. Y. Acad. Sci. 2011, 1215, 103-108. [CrossRef] [PubMed]
7. Brasnyo, P.; Molnár, G.A.; Mohás, M.; Markó, L.; Laczy, B.; Cseh, J.; Mikolás, E.; Szijártó, I.A.; Mérei, A.; Halmai, R.; et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106, 383-389. [CrossRef] [PubMed]
8. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493-506. [CrossRef] [PubMed]
9. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.; et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342. [CrossRef] [PubMed]
10. Pham-Marcou, T.A.; Beloeil, H.; Sun, X.; Gentili, M.; Yaici, D.; Benoit, G.; Benhamou, D.; Mazoit, J.X. Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: Prolonged effect related to COX-2 expression impairment. Pain 2008, 140, 274-283. [CrossRef] [PubMed]
11. Csaki, C.; Mobasheri, A.; Shakibaei, M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: Inhibition of IL-1beta-induced NF-κB-mediated inflammation and apoptosis. Arthritis Res. Ther. 2009, 11, R165. [CrossRef] [PubMed]
12. Tili, E.; Michaille, J.J.; Adair, B.; Alder, H.; Limagne, E.; Taccioli, C.; Ferracin, M.; Delmas, D.; Latruffe, N.; Croce, C.M. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010, 31, 1561-1566. [CrossRef] [PubMed]
13. Calamini, B.; Ratia, K.; Malkowski, M.G.; Cuendet, M.; Pezzuto, J.M.; Santarsiero, B.D.; Mesecar, A.D. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem. J. 2010, 429, 273-282. [CrossRef] [PubMed]
14. Hwang, S.H.; Wecksler, A.T.; Wagner, K.; Hammock, B.D. Rationally designed multitarget agents against inflammation and pain. Curr. Med. Chem. 2013, 20, 1783-1799. [CrossRef] [PubMed]
15. Cano, M.; Thimmalappula, R.; Fujihara, M.; Nagai, N.; Sporn, M.; Wang, A.L.; Neufeld, A.H.; Biswal, S.; Handa, J.T. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration. Vis. Res. 2010, 50, 652-664. [CrossRef] [PubMed]
16. Sheu, S.J.; Liu, N.C.; Chen, J.L. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J. Ocul. Pharmacol. Ther. 2010, 26, 231-236. [CrossRef] [PubMed]
17. Pintea, A.; RuginǍ, D.; Pop, R.; Bunea, A.; Socaciu, C.; Diehl, H.A. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J. Ocul. Pharmacol. Ther. 2011, 27, 315-321. [CrossRef] [PubMed]
18. Zheng, Y.; Liu, Y.; Ge, J.; Wang, X.; Liu, L.; Bu, Z.; Liu, P. Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression. Mol. Vis. 2010, 16, 1467-1474. [PubMed]
19. Luna, C.; Li, G.; Liton, P.B.; Qiu, J.; Epstein, D.L.; Challa, P.; Gonzalez, P. Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem. Toxicol. 2009, 47, 198-204. [CrossRef] [PubMed]
20. Ghiringhelli, F.; Rebe, C.; Hichami, A.; Delmas, D. Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents. Anticancer Agents Med. Chem. 2012, 12, 852-873. [CrossRef] [PubMed]
21. Latruffe, N.; Lançon, A.; Frazzi, R.; Aires, V.; Delmas, D.; Michaille, J.J.; Djouadi, F.; Bastin, J.; Cherkaoui-Malki, M. Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation. Ann. N. Y. Acad. Sci. 2015, 1348, 97-106. [CrossRef] [PubMed]
22. Zykova, T.A.; Zhu, F.; Zhai, X.; Ma, W.Y.; Ermakova, S.P.; Lee, K.W.; Bode, A.M.; Dong, Z. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol. Carcinog. 2008, 47, 797-805. [CrossRef] [PubMed]
23. Kundu, J.K.; Shin, Y.K.; Surh, Y.J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochem. Pharmacol. 2006, 72, 1506-1515. [CrossRef] [PubMed]
24. Joussen, A.M.; Poulaki, V.; Le, M.L.; Koizumi, K.; Esser, C.; Janicki, H.; Schraermeyer, U.; Kociok, N.; Fauser, S.; Kirchhof, B.; Kern, T.S.; et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004, 18, 1450-1452. [CrossRef] [PubMed]
25. Ambati, J.; Anand, A.; Fernandez, S.; Sakurai, E.; Lynn, B.C.; Kuziel, W.A.; Rollins, B.J.; Ambati, B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9, 1390-1397. [CrossRef] [PubMed]
26. Kubota, S.; Kurihara, T.; Mochimaru, H. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor κB activation. Investig. Ophthalmol. Vis. Sci. 2009, 50, 3512-3519. [CrossRef] [PubMed]
27. Blobaum, A.L.; Marnett, L.J. Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem. 2007, 50, 1425-1441. [CrossRef] [PubMed]
28. Losso, J.N.; Truax, R.E.; Richard, G. Trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J. Agric. Food Chem. 2010, 58, 8246-8252. [CrossRef] [PubMed]
29. Lançon, A.; Latruffe, N.; Lizard, G. The in vitro anti-inflammatory and anti-angiogenic potential of a new resveratrol-based formula (Resvega). In Proceedings of the EVER (European Association for Vision and Eye Meeting, Nice, France, 10-13 October 2012.
30. Latruffe, N.; Lançon, A.; Limagne, E.; Michaille, J.-J. Bioreactivity of resveratrol towards inflammation processes. In Recent Advances in Redox Active Plant and Microbial Products; Jacob, C., Kirsch, G., Slusarenko, A., Winyard, P.G., Burkholz, T., Eds.; Springer Science: Heidelberg, Germany, 2014; pp. 193-207.
31. Brakenhielm, E.; Cao, R.; Cao, Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 2001, 15, 1798-1800. [CrossRef] [PubMed]
32. -/- mice. Investig. Ophthalmol. Vis. Sci. 2011, 52, 2809-2816. [CrossRef] [PubMed]
33. Yang, S.F.; Lee, W.J.; Tan, P.; Tang, C.H.; Hsiao, M.; Hsieh, F.K.; Chien, M.H. Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas. Oncotarget 2015, 6, 2736-2753. [CrossRef] [PubMed]
34. Han, G.; Xia, J.; Gao, J.; Inagaki, Y.; Tang, W.; Kokudo, N. Anti-tumor effects and cellular mechanisms of resveratrol. Drug Discov. Ther. 2015, 9, 1-12. [CrossRef] [PubMed]
35. Bola, C.; Bartlett, H.; Eperjesi, F. Resveratrol and the eye: Activity and molecular mechanisms. Graefes Arch. Clin. Exp. Ophthalmol. 2014, 252, 699-713. [CrossRef] [PubMed]
36. Dugas, B.; Charbonnier, S.; Baarine, M.; Ragot, K.; Delmas, D.; Ménétrier, F.; Lherminier, J.; Malvitte, L.; Khalfaoui, T.; Bron, A.; et al. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: Cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur. J. Nutr. 2010, 49, 435-446. [CrossRef] [PubMed]